Literature DB >> 1939380

Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats.

Y Izumi1, S Roussel, E Pinard, J Seylaz.   

Abstract

The effects of magnesium, an endogenous inhibitor of calcium entry into neurons, upon ischemic brain damage were investigated using a well-characterized model of focal cerebral ischemia in rats. Infarct volumes were determined by 2,3,5-triphenyltetrazolium chloride transcardiac perfusion 48 h after middle cerebral artery (MCA) occlusion. The area of ischemic damage was quantified by image analysis in coronal sections taken every 0.5 mm. MgCl2 (1 mmol/kg) was injected intraperitoneally just after MCA occlusion and again 1 h later. Posttreatment with MgCl2 (16 control and 16 treated rats) significantly reduced the cortical infarct volume. Compensation for the hyperglycemic effect of MgCl2 with insulin (17 rats) further reduced the infarct volume in the neocortex. No systemic effects of either treatment could account for the observed neuroprotection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1939380     DOI: 10.1038/jcbfm.1991.170

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  28 in total

1.  A new look at glutamate and ischemia: NMDA agonist improves long-term functional outcome in a rat model of stroke.

Authors:  Jasbeer Dhawan; Helene Benveniste; Zhongchi Luo; Marta Nawrocky; S David Smith; Anat Biegon
Journal:  Future Neurol       Date:  2011-11-01

Review 2.  Vitamins and nutrients as primary treatments in experimental brain injury: Clinical implications for nutraceutical therapies.

Authors:  Cole Vonder Haar; Todd C Peterson; Kris M Martens; Michael R Hoane
Journal:  Brain Res       Date:  2015-12-23       Impact factor: 3.252

Review 3.  Magnesium neuroprotection is limited in humans with acute brain injury.

Authors:  J Andrew McKee; Randall P Brewer; Gary E Macy; Cecil O Borel; James D Reynolds; David S Warner
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

Review 4.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

Review 5.  Clinical trials for cytoprotection in stroke.

Authors:  Lise A Labiche; James C Grotta
Journal:  NeuroRx       Date:  2004-01

Review 6.  A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion.

Authors:  Ligen Shi; Marcelo Rocha; Rehana K Leak; Jingyan Zhao; Tarun N Bhatia; Hongfeng Mu; Zhishuo Wei; Fang Yu; Susan L Weiner; Feifei Ma; Tudor G Jovin; Jun Chen
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-07       Impact factor: 6.200

7.  Incidence, hemodynamic, and electrical characteristics of spreading depolarization in a swine model are affected by local but not by intravenous application of magnesium.

Authors:  Edgar Santos; Fiorella León; Humberto Silos; Renan Sanchez-Porras; C William Shuttleworth; Andreas Unterberg; Oliver W Sakowitz
Journal:  J Cereb Blood Flow Metab       Date:  2016-09-28       Impact factor: 6.200

8.  Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial.

Authors:  Chelsea S Kidwell; Kennedy R Lees; Keith W Muir; Christopher Chen; Stephen M Davis; Deidre A De Silva; Christopher J Weir; Sidney Starkman; Jeffry R Alger; Jeffrey L Saver
Journal:  Stroke       Date:  2009-03-19       Impact factor: 7.914

9.  Hyperacute therapies for childhood stroke: a case report and review of the literature.

Authors:  Jose Irazuzta; Kevin J Sullivan
Journal:  Neurol Res Int       Date:  2010-08-19

Review 10.  Management of raised intracranial pressure.

Authors:  J D Pickard; M Czosnyka
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.